Xylem Inc.
▲ 0 upgrades / ▼ 0 downgrades / 7 reiterations from 7 firms
Oct 27, 2026 (1 day)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Oct 15, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Oct 14, 2026 | Oppenheimer | reiterate | Outperform → Outperform | — | 52% |
| Oct 14, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Oct 13, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Oct 12, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Oct 5, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 24, 2026 | Jefferies | maintain | Buy → Buy | — | 52% |
| Aug 13, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 30, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 29, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 29, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Jul 29, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 29, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 29, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 20, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 16, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 25, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| Apr 29, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 29, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Apr 29, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Apr 29, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 29, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Apr 21, 2026 | UBS | downgrade | Buy → Neutral | — | 54% |
| Apr 16, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Apr 14, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Apr 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 1, 2026 | Oppenheimer | reiterate | Outperform → Outperform | — | 52% |
| Feb 11, 2026 | RBC Capital | maintain | Outperform → Outperform | $162 | 55% |
| Feb 11, 2026 | Stifel | maintain | Buy → Buy | $175 | 53% |
| Feb 11, 2026 | Citigroup | maintain | Buy → Buy | $174 | 54% |
| Feb 11, 2026 | Barclays | maintain | Overweight → Overweight | $156 | 53% |
| Jan 26, 2026 | William Blair | initiate | — → Outperform | $0 | 48% |
| Jan 7, 2026 | Barclays | maintain | Overweight → Overweight | $166 | 53% |
| Jan 5, 2026 | Mizuho | maintain | Neutral → Neutral | $150 | 52% |
| Dec 5, 2025 | TD Cowen | maintain | Hold → Hold | $135 | 54% |
| Nov 6, 2025 | UBS | maintain | Buy → Buy | $175 | 54% |
| Oct 29, 2025 | Citigroup | maintain | Buy → Buy | $182 | 54% |
| Oct 29, 2025 | Stifel | maintain | Buy → Buy | $178 | 53% |
| Oct 29, 2025 | RBC Capital | maintain | Outperform → Outperform | $176 | 55% |
| Oct 29, 2025 | Barclays | maintain | Overweight → Overweight | $172 | 53% |
| Oct 9, 2025 | Citigroup | maintain | Buy → Buy | $173 | 54% |
| Sep 19, 2025 | Barclays | initiate | — → Overweight | $165 | 53% |
| Sep 12, 2025 | Mizuho | maintain | Neutral → Neutral | $140 | 52% |
| Aug 26, 2025 | TD Cowen | maintain | Hold → Hold | $130 | 54% |
| Aug 5, 2025 | UBS | maintain | Buy → Buy | $168 | 54% |
| Aug 1, 2025 | Stifel | maintain | Buy → Buy | $175 | 53% |
| Jul 21, 2025 | Stifel | maintain | Buy → Buy | $162 | 53% |
| Jul 14, 2025 | Citigroup | maintain | Buy → Buy | $152 | 54% |
| May 30, 2025 | JP Morgan | initiate | — → Overweight | $148 | 55% |
No cross-platform signals in the last 90 days